The company launched Chlorpromazine Hydrochloride, an injectable used to treat psychiatric ... the brokerage expects 11% ...

This came after Piramal Pharma’s division Piramal Critical Care (PCC) announced the US launch of Chlorpromazine Hydrochloride Injection which will be offered in 25mg/1mL and 50mg/2 mL vials .

Piramal Pharma said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market. Chlorpromazine Hydrochloride ...

Hydrochloride for Injection, USP in two vial sizes: 25 mg/1 mL and 50 mg/2 mL, further broadening PCC's increasing portfolio of generic injectables.

Piramal Pharma Ltd on Wednesday (January 22) said its division Piramal Critical Care (PCC) has announced the US launch of Chlorpromazine Hydrochloride for Injection, USP. The product will be available ...

HCL Technologies shares dropped 9.23% after the company reported a 6% net profit growth for Q3 at Rs 4,591 crore. Revenue rose to Rs 29,890 crore. New deal bookings reached $2.1 billion. Analysts ...

The additive consists of a molecule known as 4-guanidinobenzoic acid hydrochloride (GBAC), which is a raw material and intermediate commonly utilized in organic synthesis, pharmaceuticals ...